Medical Specialty >> Gynecology

Doctors Lounge - Gynecology Answers

Back to Gynecology Answers List

If you think you may have a medical emergency, call your doctor or 911 immediately. Doctors Lounge (www.doctorslounge.com) does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site.

DISCLAIMER: The information provided on www.doctorslounge.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Please read our 'Terms and Conditions of Use' carefully before using this site.

Date of last update: 10/14/2017.

Forum Name: Obstetrics

Question: Avandia during pregnancy


 ananiahrivera - Tue Jul 12, 2005 12:52 am

I would like to know if avandia is safe during pregnancy.
I have PCOS and to help me conceive, my OB gave me clomid 100mg/day + 1 avandia 4mg/day. She said that I should take this up until the early stage of pregnancy.
Today, I learned that I'm pregnant (+ HPT) but since my OB was not available, I consulted another one. I told her the meds that I'm taking but she said that I should stop avandia right away because it could harm the fetus.
I'm also taking duvadilan and duphaston 3x/day.
Who should I follow, should I stop the avandia or not. What are the effects if I stop avandia? I'm on my fourth week, my last period was June 11, 2005.
 Dr. Anthony Solomon - Tue Jul 12, 2005 8:02 am

Avandia (rosiglitazone) is contra-indicated in pregnancy. The manufacturer advises "avoid in pregnancy - toxicity seen in animal studies".

Dr Anthony Solomon

| Check a doctor's response to similar questions

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us